Physician profile
William A Madison
NPI 1255347365
$2,347.67
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,413 · 2020: $153 · 2021: $99.00 · 2022: $436 · 2023: $140 · 2024: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $434.40 | 2019-2022 | |
| Amgen INC. | $403.80 | 2019-2024 | Repatha |
| Abbvie INC. | $224.23 | 2019-2023 | |
| Novo Nordisk INC | $219.68 | 2019 | |
| Pfizer INC. | $214.53 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $195.99 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.01 | 2022 | |
| Janssen Pharmaceuticals, INC | $94.11 | 2019 | |
| Lilly USA, LLC | $70.05 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.07 | 2019 | |
| Merck Sharp & Dohme LLC | $51.96 | 2019 | |
| Cardiovascular Systems INC. | $45.26 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $38.94 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.65 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $27.75 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $27.71 | 2019 | |
| Jazz Pharmaceuticals INC. | $27.43 | 2019 | |
| Glaxosmithkline, LLC. | $14.54 | 2019 | |
| Kaleo, INC. | $13.68 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.57 | 2019 | |
| Amarin Pharma, INC. | $13.57 | 2019 | |
| Sanofi Pasteur INC. | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Madison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.